112 related articles for article (PubMed ID: 4006474)
1. Hemodynamic studies in chronic dialysis patients with a polysulfone hemodiafilter.
Jahn H; Bauler M; Schohn D
Contrib Nephrol; 1985; 46():151-61. PubMed ID: 4006474
[No Abstract] [Full Text] [Related]
2. Ultrafiltration using the polysulfone membrane to reduce the cytokine-inducing activity of contaminated dialysate.
Lonnemann G; Schindler R
Clin Nephrol; 1994 Jul; 42 Suppl 1():S37-43. PubMed ID: 7923982
[No Abstract] [Full Text] [Related]
3. Pulmonary hypertension in hemodialysis patients without arteriovenous fistula: the effect of dialyzer composition.
Kiykim AA; Horoz M; Ozcan T; Yildiz I; Sari S; Genctoy G
Ren Fail; 2010; 32(10):1148-52. PubMed ID: 20954973
[TBL] [Abstract][Full Text] [Related]
4. Influence of various membranes on the coagulation system during dialysis.
Hildebrand U; Quellhorst E
Contrib Nephrol; 1985; 46():92-101. PubMed ID: 4006482
[No Abstract] [Full Text] [Related]
5. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
[TBL] [Abstract][Full Text] [Related]
6. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
McCarthy JT; Jenson BM; Squillace DP; Williams AW
Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
[TBL] [Abstract][Full Text] [Related]
7. The next generation of dialysis membranes--barriers or pathways?
Streicher E; Schneider H
Contrib Nephrol; 1985; 44():127-36. PubMed ID: 3987283
[No Abstract] [Full Text] [Related]
8. Permeability for middle and higher molecular weight substances. Comparison between polysulfone and cuprophan dialyzers.
Brunner H; Mann H; Stiller S; Sieberth HG
Contrib Nephrol; 1985; 46():33-42. PubMed ID: 4006479
[No Abstract] [Full Text] [Related]
9. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure].
Starzyk J; Bartelik S; Sarnecka S
Wiad Lek; 1994 Jul; 47(13-14):523-6. PubMed ID: 7716940
[TBL] [Abstract][Full Text] [Related]
10. [Antioxidants and malondialdehyde during hemodialysis with cellulose diacetate and polysulfone membranes].
Eiselt J; Racek J; Holecek V; Krejcová I; Opatrný K
Cas Lek Cesk; 1996 Nov; 135(21):691-4. PubMed ID: 8998818
[TBL] [Abstract][Full Text] [Related]
11. [The effect of repeated use of cuprophane and polysulfone dialyzers during hemodialysis on the count of natural killer cells in blood].
Liszka M; Moczulski D; Zukowska-Szczechowska E; Grzeszczak W; Religa Z
Pol Arch Med Wewn; 1997 Mar; 97(3):224-31. PubMed ID: 9333768
[TBL] [Abstract][Full Text] [Related]
12. Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers.
Thalhammer F; Kletzmayr J; El Menyawi I; Kovarik J; Rosenkranz AR; Traunmüller F; Hörl WH; Burgmann H
Am J Kidney Dis; 1998 Oct; 32(4):642-5. PubMed ID: 9774127
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility and hemodynamic studies during polycarbonate versus cuprophane membrane dialysis.
Schohn DC; Jahn HA; Eber M; Hauptmann G
Blood Purif; 1986; 4(1-3):102-11. PubMed ID: 3730154
[TBL] [Abstract][Full Text] [Related]
14. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
[No Abstract] [Full Text] [Related]
15. The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients.
Petersen J; Moore RM; Kaczmarek RG; Singh B; Yeh I; Hamburger S; Kankam M
Am J Kidney Dis; 1991 Feb; 17(2):174-8. PubMed ID: 1992659
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive evaluation of acute immunological changes induced by cuprophane and polysulfone membranes in a patient on chronic hemodialysis.
Patarca R; Perez G; Gonzalez A; Garcia-Morales RO; Gamble R; Klimas N; Fletcher MA
Am J Nephrol; 1992; 12(4):274-8. PubMed ID: 1481878
[TBL] [Abstract][Full Text] [Related]
17. Disordered breathing patterns during bicarbonate hemodialysis in COPD. Effect of cuprophane versus polysulfone membranes.
Navarro J; Serrano C; Donna E; Perez GO
ASAIO J; 1992; 38(4):811-4. PubMed ID: 1450477
[TBL] [Abstract][Full Text] [Related]
18. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients.
Muniz-Junqueira MI; Braga Lopes C; Magalhães CA; Schleicher CC; Veiga JP
Life Sci; 2005 Nov; 77(25):3141-55. PubMed ID: 16005905
[TBL] [Abstract][Full Text] [Related]
19. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications.
Kadiri S; Kehinde Z; Arije A; Salako BL
Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127
[TBL] [Abstract][Full Text] [Related]
20. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
